Diagnosis and Treatment of Renal Artery Stenosis
When to Investigate for Renal Artery Stenosis
Investigate patients who present with 2 or more of the following clinical clues 1:
- Sudden onset or worsening of hypertension with age >55 or <30 years
- Abdominal bruit
- Hypertension resistant to 3 drugs
- Serum creatinine increase ≥30% with ACE inhibitor or ARB use
- Other atherosclerotic vascular disease (especially in smokers or those with dyslipidemia)
- Recurrent pulmonary edema with hypertensive surges
For fibromuscular dysplasia (FMD), investigate with at least 1 of these clues 1:
- Unexplained kidney size asymmetry >1.5 cm
- Abdominal bruit without apparent atherosclerosis
- FMD in another vascular territory
- Family history of FMD
Imaging Modalities for Diagnosis
For Atherosclerotic Renal Artery Stenosis
The recommended screening tests are 1:
- CT angiography (CTA)
- MR angiography (MRA) - for patients with eGFR >30 mL/min/1.73 m²
- Doppler ultrasonography
- Captopril-enhanced radioisotope renal scan - only for patients with eGFR >60 mL/min/1.73 m²
Important caveat: In patients with severely reduced kidney function (eGFR <30 mL/min/1.73 m²), the diagnostic test should be selected case-by-case in consultation with a nephrologist. MRA with gadolinium is not universally recommended in this population; consider unenhanced MRI, CT, ultrasound, or scintigraphy first 1.
For Fibromuscular Dysplasia
Both CTA and MRA are recommended with similar sensitivity and specificity 1.
Practical Considerations
While Doppler ultrasound is widely used due to cost-effectiveness and lack of contrast/radiation exposure 2, 3, it can produce false-negative results even with high-grade stenosis 4. CTA and MRA provide superior anatomic detail and are more reliable for detecting significant stenosis 2, 5.
Treatment of Hypertension Secondary to Renal Artery Stenosis
Atherosclerotic Renal Artery Stenosis
Medical management is the primary treatment because renal angioplasty and stenting offers no benefit over optimal medical therapy alone for most patients 1, 6. This is Grade B evidence based on multiple randomized trials showing no significant improvement in blood pressure control, renal function, or mortality with revascularization compared to medical therapy 7, 8.
Medical therapy should include:
- ACE inhibitors or ARBs (except in bilateral stenosis)
- Thiazide diuretics at appropriate doses
- Calcium channel blockers
- Additional agents as needed for blood pressure control
Renal artery angioplasty and stenting could be considered only for patients with 1, 6:
- Uncontrolled hypertension resistant to maximally tolerated pharmacotherapy
- Progressive renal function loss
- Acute pulmonary edema
These represent the only scenarios where revascularization may provide benefit beyond medical therapy, though even here the evidence is limited to observational data and post-hoc analyses 7.
Fibromuscular Dysplasia
Renal artery angioplasty WITHOUT stenting is the recommended treatment 1, 6. This differs fundamentally from atherosclerotic disease because FMD responds much better to revascularization.
- Stenting should only be used if periprocedural dissection occurs
- Surgical revascularization is reserved for complex lesions not amenable to angioplasty, stenosis with complex aneurysm, or restenosis after 2 unsuccessful angioplasty attempts
- All patients with confirmed renal FMD should be referred to a hypertension specialist 1, 6
Critical Pitfalls to Avoid
Do not routinely perform revascularization for atherosclerotic renal artery stenosis - the evidence clearly shows no benefit over medical therapy for most patients, and procedures carry substantial risks 7, 8.
Monitor for creatinine elevation with ACE inhibitors/ARBs - 10-20% of patients may develop unacceptable rises in creatinine, particularly with volume depletion or bilateral stenosis 7.
Do not rely solely on Doppler ultrasound - while convenient and widely used, it can miss significant stenosis 4. Consider CTA or MRA for confirmation when clinical suspicion is high.
Distinguish between atherosclerotic disease and FMD - treatment approaches differ dramatically, with FMD having much better outcomes with revascularization 1, 6.